Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 05.02.2025
Formycon AG
Press Release // February 05, 2025
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Planegg-Martinsried, Germany – Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global commercialization rights of FYB203/AHZANTIVE®1 (aflibercept [ … ]
Tue, 04.02.2025
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items
SCHOTT Pharma held its Annual General Meeting virtually on February 4, 2025
All items on the agenda were approved by shareholders
Dr. Wolfram Carius has been appointed to SCHOTT Pharma’s Supervisory Board, replacing Dr. Wolfgang Wienand
SCHOTT Pharma, [ … ]
Tue, 04.02.2025
dormakaba Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Rümlang, 4 February 2025 – dormakaba today announces that it is expecting to report a significant increase in reported operating profit (EBIT, Earnings before interest and taxes) and net profit for the first half-year 2024/25 for the period ending 31 December 2024 relative to the period ending 31 December [ … ]
Tue, 04.02.2025
Edison Investment Research Limited
London, UK, 4 February 2025
Edison issues report on Finsbury Growth & Income Trust (FGT)
Edison issues report on Finsbury Growth & Income Trust (LSE: FGT).
Finsbury Growth & Income Trust’s (FGT’s) portfolio has changed considerably since 2019. There is a greater exposure to digital winners, which now make up close to two-thirds [ … ]
Tue, 04.02.2025
Evolva Holding SA
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Shareholder Clearway requests general meeting
Reinach, Switzerland, 4 February 2025 — Evolva Holding SA (SIX: EVE) ("Evolva") received a letter yesterday by its largest shareholder Clearway Capital Partners ICAV, Dublin, Ireland ("Clearway") in which Clearway requests a general meeting [ … ]
Tue, 04.02.2025
Kudelski Group
Kudelski Group
/ Key word(s): Miscellaneous
The Kudelski Group announces transformation
and cost reductions
04.02.2025 / 17:40 CET/CEST
Ad hoc announcement pursuant to Art. 53 LR
Simplification of Group structure with a new focus on core digital security technologies
Kudelski Security will extend its expertise to O [ … ]
Tue, 04.02.2025
4finance S.A.
4finance EUR 2028 bond put option notification
4 February 2025. 4finance S.A. (“4finance” or the “Company”) notifies investors that it has published a put option notice in respect of its 11.25% EUR 2028 bonds, as per the Terms and Conditions amended in December 2023. Upon request from investors the Company may repurchase up to a total of EUR 15 [ … ]
Tue, 04.02.2025
Sun Tekstil
EQS-Media / 04.02.2025 / 15:17 CET/CEST
London, UK – Ekoten Tekstil, a subsidiary of Sun Tekstil, a leading force in textile manufacturing, is transforming production with artificial intelligence (AI)-powered defect detection, ensuring superior fabric quality while reinforcing its leadership in sustainability. The company’s real-time AI moni [ … ]
Tue, 04.02.2025
Laxxon Medical
Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LMX.5 New York, 02/04/2025 / 09:01, EST/EDT - EQS Newswire - Laxxon Medical
Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery systems, today announced the p [ … ]
Tue, 04.02.2025
EMERAM Capital Partners GmbH
Rivean Capital and EMERAM Portfolio Update:
]init[ AG Expands its Healthcare Business with the Acquisition of HBSN Group
Berlin, 04 February 2025 – HBSN Group is now fully owned by ]init[ AG für digitale Kommunikation. This strategic combination creates a new market leader in digitalization for public administration and healthcare in Germany.
Wi [ … ]